Loading...
Last submissions
-
-
-
-
-
-
Thomas Vazquez, Léa Torrieri-Damard, Fabien Pitoiset, Béatrice Levacher, James Vigneron, et al.. Particulate antigens administrated by intranasal and intravaginal routes in a prime-boost strategy improve HIV-specific TFH generation, high-quality antibodies and long-lasting mucosal immunity. European Journal of Pharmaceutics and Biopharmaceutics, 2023, ⟨10.1016/j.ejpb.2023.08.014⟩. ⟨hal-04192860⟩
-
Antoine Fayand, Margaux Cescato, Laurent Le Corre, Alexandre Terré, Margaux Wacheux, et al.. Pathogenic variants in the NLRP3 LRR domain at position 861 are responsible for a boost-dependent atypical CAPS phenotype.. Journal of Allergy and Clinical Immunology, In press, ⟨10.1016/j.jaci.2023.07.006⟩. ⟨hal-04182567⟩
-
-
Signe Hässler, Delphine Bachelet, Julianne Duhaze, Natacha Szely, Aude Gleizes, et al.. Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium. PLoS Medicine, 2020, 17 (10), pp.e1003348. ⟨10.1371/journal.pmed.1003348⟩. ⟨hal-03054988⟩
-
Vincent Bouget, Julien Duquesne, Signe Hassler, Paul-Henry P.-H. Cournède, Bruno Fautrel, et al.. Machine Learning Predicts Response to TNF Inhibitors in Rheumatoid Arthritis: Results on the ESPOIR and ABIRISK Cohorts. RMD Open : Rheumatic & Musculoskeletal Diseases, 2022, 8 (2), pp.e002442. ⟨10.1136/rmdopen-2022-002442⟩. ⟨hal-03979132⟩
-
Julianne Duhazé, Signe Hässler, Delphine Bachelet, Aude Gleizes, Salima Hacein-Bey-Abina, et al.. A Machine Learning Approach for High-Dimensional Time-to-Event Prediction With Application to Immunogenicity of Biotherapies in the ABIRISK Cohort. Frontiers in Immunology, 2020, 11, ⟨10.3389/fimmu.2020.00608⟩. ⟨hal-03979107⟩
-
Signe Hässler, Delphine Bachelet, Julianne Duhaze, Natacha Szely, Aude Gleizes, et al.. Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium. PLoS Medicine, 2020, 17 (10), pp.e1003348. ⟨10.1371/journal.pmed.1003348⟩. ⟨hal-03979090⟩
-
-
Ewa Maria Sroka, Mathilde Lavigne, Marika Pla, Chrysoula Daskalogianni, Maria Camila Tovar-Fernandez, et al.. Major histocompatibility class I antigenic peptides derived from translation of pre-mRNAs generate immune tolerance. Proceedings of the National Academy of Sciences of the United States of America, 2023, 120 (7), pp.e2208509120. ⟨10.1073/pnas.2208509120⟩. ⟨hal-04074191⟩
-
Sophia Maschalidi, Paula Nunes-Hasler, Clarissa R Nascimento, Ignacio Sallent, Valérie Lannoy, et al.. UNC93B1 interacts with the calcium sensor STIM1 for efficient antigen cross-presentation in dendritic cells. Nature Communications, 2017, 8 (1), pp.1640. ⟨10.1038/s41467-017-01601-5⟩. ⟨hal-04059179⟩
-
-
-
A. Amara, Elyès Ben Salah, Amélie Guihot, Christine Fardeau, V. Touitoue, et al.. Étude observationnelle de l'usage du QuantiFERON® pour le diagnostic de tuberculose oculaire, basée sur 244 tests consécutifs. La Revue de Médecine Interne, 2021, 42 (3), pp.162-169. ⟨10.1016/j.revmed.2020.09.005⟩. ⟨hal-03171237⟩
-
-
Yves Allenbach, Céline Anquetil, Ali Manouchehri, Olivier Benveniste, Olivier Lambotte, et al.. Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities. Autoimmunity Reviews, 2020, 19 (8), pp.102586. ⟨10.1016/j.autrev.2020.102586⟩. ⟨hal-04003010v2⟩